Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension P P KOOPMANS, TH THIEN, F W J GRIBNAU
Introduction
Although several investigations have shown that inhibition of the synthesis of prostaglandins in the kidney by non-steroidal antiinflammatory drugs can blunt the natriuretic response during Department of Medicine, Division of General Internal Medicine, Sint Radboudhospital, PO Box 9101, Nijmegen, The Netherlands P P KOOPMANS, MD, internist TH THIEN, MD, internist F W J GRIBNAU, MD, professor of clinical pharmacology Correspondence and requests for reprints to: Dr P P Koopmans. diuretic treatment, particularly in states of high angiotensin II concentrations,'-6 published findings have agreed less on whether non-steroidal anti-inflammatory drugs can influence, in a clinically important way, the antihypertensive effect of thiazide diuretics. Several authors have reported attenuation of the effect of thiazide diuretics and other antihypertensive drugs on blood pressure as a result of indomethacin treatment in patients with hypertension.'-" For instance, when indomethacin was added to various antihypertensive drugs an increase of 14/6 mm Hg in supine blood pressure was observed8 and even of 13/9 mm Hg in patients treated with only thiazide diuretics.7 On the other hand, Steiness found only a slight (and not significant) increase in blood pressure during treatment with indomethacin but an additional decrease during treatment with sulindac.1" As sulindac is supposed to have less effect on renal prostaglandin synthesis than any other non-steroidal anti-inflammatory drug,13 14 it might have advantages in hypertensive patients receiving diuretics who need non-steroidal anti-inflammatory drugs for osteoarthritis or other rheumatic diseases.
Here we report the results of the treatment of 10 patients with essential hypertension with hydrochlorothiazide alone and hydrochlorothiazide in combination with indomethacin, naproxen, or sulindac.
Patients and methods
Ten patients (eight men, two women), aged 21-65 (mean (SD) 48 4 (113)) years, with essential hypertension, were selected from the outpatient clinic for study. We included patients with untreated supine diastolic blood pressure greater than 85 mm Hg. None of the patients had secondary hypertension, signs or symptoms of congestive heart failure, aortic valve dysfunction, or history of peptic ulcer. All patients gave their informed consent, and the local ethics committee approved the protocol. The 
Moreover, significant changes were found in none of the variables during treatment with any of the non-steroidal anti-inflammatory drugs compared with values during treatment with hydrochlorothiazide alone, with the exception of an increase in plasma potassium concentration (p <0 05) during treatment with indomethacin.
Discussion
In this three way crossover study we found that addition of a non-steroidal anti-inflammatory drug, such as indomethacin, naproxen, or sulindac, did not influence in a clinically important way the antihypertensive effect of hydrochlorothiazide. Our data contradict the results of some other studies.7 8 17 Several factors could be responsible for this difference, for instance differences in study design, time effects, dosages, or methods of measuring blood pressure.
An increase in blood pressure has previously been observed when indomethacin was added for one week to diuretic treatment in hypertensive patients.14 Longer periods of up to six weeks7 8 have also been used to show an interaction between diuretics and non-steroidal anti-inflammatory drugs. We therefore chose in our three way crossover study to give each non-steroidal antiinflammatory drug for four weeks; on the one hand this time span had been confirmed to be sufficiently long and on the other this could also elicit a temporary interaction. Moreover, washout periods, also consisting of four weeks, were used to prevent carry over effects and to provide for similar blood pressure values at the beginning of each period of treatment with non-steroidal anti-inflammatory drugs.
Our results may indeed suggest a transient interaction: the addition of indomethacin for two weeks induced a slight increase (6/3 mm Hg) in blood pressure and that of naproxen or sulindac tended to enhance the antihypertensive effect of hydrochlorothiazide, but, after four weeks' treatment with any of the three non-steroidal anti-inflammatory drugs their effects appeared to be blunted, for blood pressure values reverted to baseline. In agreement with other investigators,7 17 we also observed considerable individual variations in blood pressure during treatment with non-steroidal anti-inflammatory drugs.
In accordance with published findings, adding indomethacin to diuretic treatment increased body weight and attenuated the decrease in plasma potassium concentration by hydrochlorothiazide. 5-No other significant changes were observed for various biochemical variables.
One disadvantage of this study may have been its open character, as compared with some double blind placebo controlled studies.7 8 In contrast to these, however, we used a strictly prospective design and we measured blood pressure in each period of four weeks on two occasions with both a sphygmomanometer (the subjective method), and an arteriosonde (the objective method), being a blind method. Moreover, we emphasise that these values gained by arteriosonde were means of eight readings per patient on each occasion.
We cannot exclude that higher dosages of the three nonsteroidal anti-inflammatory drugs might have shown an important interaction with hydrochlorothiazide. An increase in blood pressure, however, has been shown with a dosage of indomethacin similar to that used here.7 Conversely, the dosages of the three non-steroidal anti-inflammatory drugs were usual for the treatment of osteoarthritis and arthritic disorders. Thus higher dosages would not have been appropriate for the purpose of this study, which was to investigate whether non-steroidal anti-inflammatory drugs influence the treatment of hypertension when these drugs are necessary for concomitant locomotor diseases.
From a theoretical point of view sulindac might be preferred as the non-steroidal anti-inflammatory drug of choice in patients treated with thiazides as it showed possibly minor effects on renal prostaglandin synthesis"3 14 18 compared with indomethacin and naproxen.' This study, however, did not establish the clinical relevance of this difference as addition of all three non-steroidal anti-inflammatory drugs to hydrochlorothiazide resulted only in marginal and transient effects on blood pressure.
